A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP

NCT07343310 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

DRUG: KINE-101

Sponsor

Kine Sciences Co., Ltd.